A stable isotope dilution LC–ESI-MS/MS method for the quantification of pyridoxal-5′-phosphate in whole blood

Abstract

Vitamin B6 is a cofactor in numerous biologic processes that include gluconeogenesis, neurotransmitter synthesis and amino acid metabolism. The aim of this study was to develop a method to measure the concentration of the biologically active form of vitamin B6 (pyridoxal-5′-phosphate, PLP) in whole blood with stable isotope dilution LC–ESI-MS/MS and compare this new procedure with an established HPLC method based on derivatization of pyridoxal-5′-phosphate. 50μl of stable isotope (PLP-d3) was added to 250μl of sample, followed by deproteinization with 10% trichloroacetic acid. After centrifugation, 20μl of the supernatant was injected into the LC–ESI-MS/MS. Reversed phase chromatography was performed on a UPLC system, using a Waters™ Symmetry C18 column, with a gradient of 0.1% formic acid in methanol. PLP was measured on a tandem MS with a mass transition of 247.8>149.8 in the positive ion mode with a collision energy of 14eV. The chromatographic run lasted 4min. The method was linear from 4 to 8000nmol/l. The intra-day and inter-day precision ranged between 1.7–2.8% and 3.0–4.1%, respectively. The mean absolute matrix-effect was 99.3% [97–102%]. The relative matrix-effect was 98.8%. The mean recovery was 98% [89–103%]. The lower limit of quantification was 4nmol/l. The comparison of the LC–ESI-MS/MS method with our current HPLC method yielded the following equation: LC–ESI-MS/MS=1.11 [confidence interval, CI: 1.03–1.20]×HPLC+4.6 [CI: −1.3 to 11.0] (r2=0.94). This LC–ESI-MS/MS based method is characterized by simple sample processing and a short run time. The comparison with the current HPLC method is excellent although a significant proportional bias was detected. To conclude, the LC–ESI-MS/MS method is an appropriate method to determine PLP in whole blood.